Cryoport and Sanaria Expand Logistics Partnership Supporting Malaria Vaccines

Cryoport, Inc. (OTCBB: CYRX), provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is enhancing its cryogenic logistics support of its Sanaria partnership, which includes Sanaria’s production of malaria vaccine as well as its research and development efforts.  Click here for more information.